Trial Profile
A study of T-type Calcium Channel Blocker for the treatment of neurological disorders
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2016
Price :
$35
*
At a glance
- Drugs Calcium channel antagonists (Primary)
- Indications Neurological disorders
- Focus Adverse reactions
- 08 Sep 2016 New trial record